Forxiga - Dapagliflozin

What is it?

Composition

Forxiga tablets contain:

• Active ingredient: dapagliflozin
• Strength sold on this page: 10 mg per tablet

How to use?

Forxiga is taken by mouth. It can be taken with or without food.

• Standard adult dose: 10 mg once daily
• Timing: take it at the same time each day
• Administration: swallow the tablet whole with water
• Missed dose: take the next dose at the usual time; do not take two doses together

How does it work?

Forxiga works in the kidneys by inhibiting the sodium-glucose cotransporter 2 (SGLT2). SGLT2 is responsible for reabsorbing glucose back into the bloodstream. When you block it, more glucose leaves the body via urine, which lowers blood glucose levels without relying on insulin secretion ^[1].

Dapagliflozin belongs to the gliflozin class. You may see the chemical form referenced in clinical databases as dapagliflozin propanediol, which relates to the salt/complex used to deliver dapagliflozin in a stable oral form.

Indications

Forxiga is a medicine from the SGLT2 inhibitor group, and its active ingredient is dapagliflozin. Clinicians use it in adult type 2 diabetes to improve glycaemic control, often alongside lifestyle changes and other glucose-lowering medicines. For certain patients, it is also used as part of long-term treatment plans for chronic heart failure and chronic kidney disease, where reducing kidney workload and fluid congestion can be clinically meaningful.

Comparison

Forxiga sits within the gliflozin class, so it shares a family profile with other SGLT2 inhibitors. Similarities include glucose lowering via urinary glucose excretion, mild diuresis, and class warnings about genital infections and ketoacidosis.

Differences across the class tend to be about:

• Labelled indications (which heart failure or CKD populations are included)
• Renal function thresholds for starting/continuing therapy
• Strength of outcomes evidence in specific patient groups

WHO guidance on essential medicines and therapeutic use across populations often frames SGLT2 inhibitors as part of modern cardiometabolic risk reduction, not only glucose control ^[4].

Contraindications

Do not use Forxiga if any of these apply:

• Allergy/hypersensitivity to dapagliflozin or tablet components
• Type 1 diabetes, where DKA risk is higher with SGLT2 inhibitors
• Severe renal impairment (creatinine clearance < 25 mL/min) or end-stage renal disease
• Pregnancy or breastfeeding, due to limited safety data and potential risk to the developing kidney

Not recommended for

Forxiga can be a strong choice in the right patient, and a poor choice in the wrong one. The main risks to think about are volume depletion, infections in the urinary or genital area, and diabetic ketoacidosis, which is a medical emergency.

• Avoid it if you have a true allergy to dapagliflozin or the tablet ingredients.
• It is not suitable for people with type 1 diabetes.
• It may not be appropriate if your kidney function is very low or you have end-stage kidney disease.
• It should not be used in pregnancy or while breastfeeding.
• Be extra careful if you get dehydrated, are unwell, or are having surgery.
• Low-carb or ketogenic diets can increase ketone-related risk.
• Seek urgent help for severe genital pain, swelling, fever, or feeling generally unwell.

MOHAP (Ministry of Health and Prevention) safety communications in the UAE generally emphasise medication reconciliation, kidney function monitoring, and reporting unexpected adverse events through formal pharmacovigilance channels ^[3].

Side effects

Forxiga’s side effects follow directly from how it works: more sugar in urine changes the local environment, and mild diuresis can lower blood pressure.

Commonly reported effects include:

• Urinary tract infection symptoms (burning, urgency), including cystitis
• Genital yeast infections (itching, irritation, discharge)
• Dehydration or low blood pressure (thirst, dizziness, feeling faint), more likely with hot weather or fasting
• Hypoglycaemia risk rises when combined with insulin or sulfonylureas (sweating, tremor, confusion)

A short sentence that matters: ketoacidosis can happen.
It can occur with near-normal glucose.

Common mistakes

People do not “fail” Forxiga because the drug is weak; they often run into predictable pitfalls.

Frequent mistakes seen in practice:

• Doubling the next dose after a missed tablet, which increases dehydration and dizziness risk without giving smoother glucose control
• Starting a strict ketogenic diet at the same time, then ignoring nausea or abdominal pain that could signal ketosis
• Treating recurrent genital symptoms with repeated OTC antifungals without addressing triggers, leading to cycles of irritation
• Not adjusting other glucose-lowering medicines (insulin/sulfonylurea), then blaming Forxiga for hypoglycaemic episodes
• Skipping fluids during UAE hot months, then feeling faint and stopping the medicine abruptly

Doctor opinions

In clinical practice, endocrinologists like Forxiga when a patient needs glucose lowering without pushing insulin levels higher, since the mechanism is kidney-based rather than pancreas-stimulating. Cardiologists often describe SGLT2 inhibitors as “foundational therapy” in eligible chronic heart failure patients because benefits can appear even without diabetes, and they tend to fit alongside beta-blockers and RAAS inhibitors.

A small, real-world nuance: the first follow-up after starting Forxiga is often about symptoms, fluids, and blood pressure, not just glucose numbers.

Frequently asked questions

How quickly does Forxiga work, and how is the timeline measured?

Forxiga begins increasing urinary glucose excretion after the first doses, so some glucose lowering can appear early. HbA1c improvement is usually assessed over weeks because HbA1c reflects an average across roughly three months. Heart failure symptom changes, when they occur, can show within a few weeks, while kidney-protection outcomes are tracked over longer follow-up. The EMA product information summarises these timelines and endpoints used in clinical trials .

Does Forxiga cause low blood sugar?

Forxiga alone has a low hypoglycaemia risk because it does not force insulin release. The risk changes when it is combined with insulin or sulfonylureas, where dose adjustments are often needed. Symptoms like sweating, tremor, palpitations, or confusion should be treated as hypoglycaemia until proven otherwise. The FDA label for dapagliflozin highlights this interaction pattern and the need for monitoring in combination regimens .

Can Forxiga be used for chronic kidney disease?

Forxiga is used in selected adults with chronic kidney disease, and benefit is considered beyond glucose lowering, depending on kidney function and the clinical scenario. Renal thresholds matter for who can start or continue therapy, and prescribers individualise based on eGFR/creatinine clearance and comorbidities. Kidney benefits are measured by slower decline in kidney function and fewer renal events over time, rather than a quick symptom change. NICE guidance outlines renal use criteria and monitoring priorities .

What monitoring is recommended with Forxiga?

Monitoring usually includes blood glucose trends (and HbA1c at follow-up), blood pressure, and renal function tests, especially early on or when other diuretics are used. People with recurrent UTIs or genital infections may need targeted prevention strategies or reassessment of therapy. In heart failure, clinicians also watch weight, swelling, and breathlessness as day-to-day signals. The FDA label for dapagliflozin lists key monitoring domains and adverse-event patterns seen in trials .

Do you offer anonymous delivery?

Front view

Side view

Back view

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (9.4x4.3x0.3 in. or 24x11x0.7 cm) and its contents cannot be seen.